156 related articles for article (PubMed ID: 9652851)
21. Combined effects of 13-cis-retinoic acid, tamoxifen and interferon on the growth of human breast cancer cells.
Lama G; Angelucci C; Recchia F; Sica G
Cancer Lett; 1996 Feb; 100(1-2):181-9. PubMed ID: 8620440
[TBL] [Abstract][Full Text] [Related]
22. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha.
Hoffmann W; Bläse MA; Santo-Hoeltje L; Herskind C; Bamberg M; Rodemann HP
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):991-8. PubMed ID: 10571207
[TBL] [Abstract][Full Text] [Related]
23. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid and interferon-alpha effects on cell growth and differentiation in cervical carcinoma cell lines.
Yokoyama M; Nakao Y; Iwasaka T; Pater A; Sugimori H
Obstet Gynecol; 2001 Aug; 98(2):332-40. PubMed ID: 11506854
[TBL] [Abstract][Full Text] [Related]
25. Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.
Huang CL; Lin ZZ; Su IJ; Chao TY; Tien HF; Chang MC; Huang MC; Kao WY; Tang JL; Yeh KH; Wang CH; Hsu CH; Liu MY; Cheng AL
Leuk Lymphoma; 2002 Jul; 43(7):1415-20. PubMed ID: 12389622
[TBL] [Abstract][Full Text] [Related]
26. Effects of retinoic acid and interferon-gamma on expression of the retinoic acid receptor in mouse renal cell carcinoma.
Hara I; Taguchi I; Miyake H; Hara S; Gotoh A; Kamidono S
Int J Oncol; 2001 Nov; 19(5):959-62. PubMed ID: 11604994
[TBL] [Abstract][Full Text] [Related]
27. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
28. 13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro.
Benthin M; Dallmann I; Atzpodien J
Cancer Biother Radiopharm; 2001 Aug; 16(4):323-31. PubMed ID: 11603003
[TBL] [Abstract][Full Text] [Related]
29. Combined effects of interferon-alpha2a and 13-cis-retinoic acid on human melanoma cell growth and STAT protein expression.
Bearzatto A; Orlandi L; Silvestrini R; Belli F; Cascinelli N; Zaffaroni N
Melanoma Res; 1998 Feb; 8(1):31-8. PubMed ID: 9508374
[TBL] [Abstract][Full Text] [Related]
30. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
31. All-trans retinoic acid and interferon-alpha for treatment of human renal cell carcinoma multicellular tumor spheroids.
Rohde D; Brkovic D; Hönig d'Orville I
Urol Int; 2004; 73(1):47-53. PubMed ID: 15263793
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines.
Toma S; Monteghirfo S; Tasso P; Nicolò G; Spadini N; Palumbo R; Molina F
Cancer Lett; 1994 Jul; 82(2):209-16. PubMed ID: 8050093
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
[TBL] [Abstract][Full Text] [Related]
35. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
36. Differential retinoic acid radiosensitization of cervical carcinoma cell lines.
Benbrook DM; Shen-Gunther J; Nuñez ER; Dynlacht JR
Clin Cancer Res; 1997 Jun; 3(6):939-45. PubMed ID: 9815769
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
[TBL] [Abstract][Full Text] [Related]
38. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.
DiPaola RS; Rafi MM; Vyas V; Toppmeyer D; Rubin E; Patel J; Goodin S; Medina M; Medina P; Zamek R; Zhang C; White E; Gupta E; Hait WN
J Clin Oncol; 1999 Jul; 17(7):2213-8. PubMed ID: 10561278
[TBL] [Abstract][Full Text] [Related]
40. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]